Neutrophil-mediated immune suppression as a mechanism of HIV-1 pathogenesis.
中性粒细胞介导的免疫抑制是 HIV-1 发病机制的一个机制。
基本信息
- 批准号:8651885
- 负责人:
- 金额:$ 18.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-15 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAntigensBacterial TranslocationBindingBloodBlood CirculationCD4 Positive T LymphocytesCD8B1 geneCell CountCell physiologyCessation of lifeChronicClinicalDataDependencyDisseminated Malignant NeoplasmDoseExhibitsHIVHIV-1Human VolunteersITGAM geneImmuneImmune systemImmunosuppressionIn VitroIndividualInfectionInjection of therapeutic agentIntegrinsInterferonsLigandsMacrophage-1 AntigenMediatingModelingNatural HistoryNeutrophil ActivationPathogenesisPathway interactionsPatientsPeripheral Blood Mononuclear CellPhenotypePlasmaPopulationProcessProductionPropertyReactive Oxygen SpeciesReportingRoleStimulusSurfaceT cell responseT-Cell ActivationT-LymphocyteTestingViralViral Load resultVirionWhole Bloodantiretroviral therapyarginasebasecytokinedensitydesignexhaustionimmune activationimmune functionin vivomicrobialneutrophilnovelparticleperipheral bloodprogramspublic health relevancevolunteer
项目摘要
DESCRIPTION (provided by applicant): Chronic immune activation and loss of T cell functional capacity are critical hallmarks of HIV-1 infection both in natural history and under antiretroviral therapy. Many aspects of the interaction between HIV-1 and the host immune system are poorly understood. Precise delineation of these mechanisms is critical for our understanding of HIV-1 pathogenesis and design of novel therapies. CD4+ and CD8+ T cells from HIV-1-infected individuals exhibit decreased responsiveness to antigenic stimuli, decreased capacity to produce cytokines and elevated surface levels of programmed death-1 (PD-1) molecule. The binding of PD-1 to its ligand PD-L1 results in an induction of anergic phenotype in T cells. Precise mechanisms underlying the relationship between microbial translocation, immune activation and loss of T cell function are not fully understood. In here we propose that a subpopulation of neutrophils, likely activated by the products of bacterial translocation, represents a major immune suppressive population in HIV-1 infection exerting a potent inhibitory activity on T cells. We show that peripheral blood neutrophils from HIV-1-infected individuals express elevated levels of PD- L1 and suppress antigen-specific and non-specific T cell responses. Depletion of neutrophils from PBMCs results in a marked increase in the proliferation and cytokine production by antigen-specific T cells. The mechanism of inhibition of T cell function by neutrophils is unclear; however preliminary data indicate that it is mediated
by PD-L1 and production of reactive oxygen species (ROS). We present a novel, as yet unrecognized mechanism of immune suppression in HIV-1-infected individuals. Importantly, our data suggest that suppressive neutrophils are induced by the products of microbial translocation and/or viral particles. Thus, we hypothesize that neutrophil-mediated inhibition of T cell function
represents a primary mechanism of immune suppression in HIV-1 infection and not a secondary effect of immune dysregulation. To further characterize the role of this novel pathway in HIV-1 pathogenesis, we propose to define the mechanisms of neutrophil-mediated immune suppression and the mechanisms of neutrophil activation and induction of suppressor phenotype in HIV-1-infected individuals. The novel model of immune suppression tested in this study may significantly alter our understanding of HIV-1 pathogenesis and result in a design of novel therapies targeting the loss of immune function in HIV-1-infected individuals.
描述(由申请人提供):慢性免疫激活和T细胞功能丧失是HIV-1感染的关键特征,无论是在自然史中还是在抗逆转录病毒治疗中。HIV-1和宿主免疫系统之间相互作用的许多方面都知之甚少。这些机制的精确描述对于我们理解HIV-1发病机制和设计新的治疗方法至关重要。来自HIV-1感染个体的CD 4+和CD 8 + T细胞表现出对抗原刺激的反应性降低、产生细胞因子的能力降低和程序性死亡-1(PD-1)分子的表面水平升高。PD-1与其配体PD-L1的结合导致T细胞中无反应性表型的诱导。微生物易位、免疫激活和T细胞功能丧失之间关系的确切机制尚未完全了解。在这里,我们提出中性粒细胞亚群可能被细菌移位产物激活,代表了HIV-1感染中主要的免疫抑制群体,对T细胞发挥着强有力的抑制活性。我们发现,HIV-1感染者的外周血中性粒细胞表达PD-L1水平升高,并抑制抗原特异性和非特异性T细胞反应。从PBMC中消耗嗜中性粒细胞导致抗原特异性T细胞的增殖和细胞因子产生显著增加。中性粒细胞抑制T细胞功能的机制尚不清楚;然而,初步数据表明,它是介导的。
PD-L1和活性氧(ROS)的产生。我们提出了一种新的,尚未认识到的免疫抑制机制,在HIV-1感染者。重要的是,我们的数据表明,抑制性中性粒细胞诱导的微生物易位和/或病毒颗粒的产品。因此,我们假设嗜中性粒细胞介导的T细胞功能抑制
代表HIV-1感染中免疫抑制的主要机制,而不是免疫失调的继发效应。为了进一步描述这种新途径在HIV-1发病机制中的作用,我们建议定义嗜中性粒细胞介导的免疫抑制机制和中性粒细胞活化机制,以及HIV-1感染者抑制表型的诱导机制。本研究中测试的免疫抑制新模型可能会显著改变我们对HIV-1发病机制的理解,并导致设计针对HIV-1感染者免疫功能丧失的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zdenek Hel其他文献
Zdenek Hel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zdenek Hel', 18)}}的其他基金
Dysregulated neutrophil subpopulations as a driving mechanism of liver and gastrointestinal disease in HIV-1-infected individuals
中性粒细胞亚群失调是 HIV-1 感染者肝脏和胃肠道疾病的驱动机制
- 批准号:
10698980 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Neutrophil dysregulation as a driving mechanism of cardiovascular disease in HIV-1-infection
中性粒细胞失调是 HIV-1 感染者心血管疾病的驱动机制
- 批准号:
9341375 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals
HIV 的本质:先天免疫失调是 HIV-1 感染者胃肠道和肝脏疾病的核心机制
- 批准号:
9049004 - 财政年份:2015
- 资助金额:
$ 18.38万 - 项目类别:
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals
HIV 的本质:先天免疫失调是 HIV-1 感染者胃肠道和肝脏疾病的核心机制
- 批准号:
9148234 - 财政年份:2015
- 资助金额:
$ 18.38万 - 项目类别:
The Guts of HIV: Innate Immune Dysregulation as a Central Mechanism of Gastrointestinal and Liver Disease in HIV-1-infected Individuals
HIV 的本质:先天免疫失调是 HIV-1 感染者胃肠道和肝脏疾病的核心机制
- 批准号:
9755236 - 财政年份:2015
- 资助金额:
$ 18.38万 - 项目类别:
Neutrophil-mediated immune suppression as a mechanism of HIV-1 pathogenesis.
中性粒细胞介导的免疫抑制是 HIV-1 发病机制的一个机制。
- 批准号:
8467290 - 财政年份:2013
- 资助金额:
$ 18.38万 - 项目类别:
Depletion of myeloid-derived suppressor cells (MDSCs) in HIV-1-infection
HIV-1 感染中骨髓源性抑制细胞 (MDSC) 的耗竭
- 批准号:
8103858 - 财政年份:2010
- 资助金额:
$ 18.38万 - 项目类别:
Depletion of myeloid-derived suppressor cells (MDSCs) in HIV-1-infection
HIV-1 感染中骨髓源性抑制细胞 (MDSC) 的耗竭
- 批准号:
7841378 - 财政年份:2010
- 资助金额:
$ 18.38万 - 项目类别:
Dysregulation of IgA responses in HIV-1-infected individuals
HIV-1 感染者 IgA 反应失调
- 批准号:
7339132 - 财政年份:2007
- 资助金额:
$ 18.38万 - 项目类别:
Dysregulation of IgA responses in HIV-1-infected individuals
HIV-1 感染者 IgA 反应失调
- 批准号:
7671484 - 财政年份:2007
- 资助金额:
$ 18.38万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 18.38万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:














{{item.name}}会员




